An increase in the prevalence of myopia is driving the market growth
Market CAGR for contact lenses is driven by most presbyopia, and myopia among children and adults is constantly growing. This, along with limited awareness and uncertainty among the general population toward eyesight modification, specifically in emerging countries, is responsible for the growing number of people with vision impairment.
Furthermore, the demand for ultra-vision contact lenses is increasing as they provide excellent vision and superb, all-day comfort to people with myopia. In the future, healthcare professionals to monitor the progress while using different contact lens types in real-time using advanced sensing techniques such as near-infrared spectroscopy. Several factors drive this growth in the contact lens market, such as the increasing prevalence of diabetes and the rising demand for contact lenses due to cataract surgery.
- The World Health Organization estimates that myopia is increasing rapidly worldwide, particularly among children and young adults exposed to prolonged screen time and limited outdoor activity. Rising refractive error prevalence is significantly increasing demand for corrective contact lenses, especially advanced daily disposable and silicone hydrogel products offering enhanced comfort and vision correction.
Additionally, the need to eliminate spectacOrthokeratologyve vision correction, the PanOptix lens delivers outstanding near, intermediate, and distance vision, eliminating the need for glasses post-surgery. This trifocal lens has revolutionized cataract surgery, offering improved quality of life for patients by minimizing the reliance on eyewear. Thanks to its innovative ENLIGHTEN® Optical Technology, the lens also provides excellent performance in low-light conditions, which further enhances its appeal.
As of today, over a million PanOptix lenses have been implanted worldwide, underscoring its success and the growing demand for presbyopia-correcting IOLs. This growth reflects the broader trend in the eye care sector, with increasing numbers of patients seeking advanced solutions for presbyopia and cataracts. Alcon’s commitment to innovation continues to position them as a leader in the IOL market, with a notable surge in interest for multifocal lenses.
-
Bausch + Lomb continues strengthening product development and innovation through advanced contact lens technologies designed for myopia management, comfort enhancement, and extended wear performance. Strategic partnerships and collaborations with eye-care professionals and research institutions support broader adoption of premium vision correction solutions, helping address the growing prevalence of refractive disorders among both pediatric and adult populations.
Furthermore, the overall contact lenses industry is experiencing significant advancements, particularly in areas such as drug-delivery capabilities and daily disposable options. As patient preferences evolve, the demand for more convenient and advanced contact lenses is expected to fuel continued growth in the sector.
Leading manufacturers are focusing on increasing their R&D investments to develop and introduce technologically advanced lenses. These lenses will be mainly used for vision correction, fueling product usage among the patient population.
- The Pan American Health Organization highlights increasing awareness regarding eye hygiene and infection prevention associated with vision correction products. Growing consumer preference for convenient and hygienic daily disposable contact lenses is boosting adoption rates, particularly among younger populations and urban consumers seeking low-maintenance vision correction alternatives to spectacles.
In 2024, CooperVision and Alcon, two leading players in the contact lens industry, have made significant strides in expanding their manufacturing capabilities and product offerings, reinforcing their commitment to innovation and sustainability.
CooperVision has continued its expansion efforts, particularly through a major project at its West Henrietta facility in New York. The 150,000-square-foot expansion increases its manufacturing, packaging, and distribution capacity, enabling the company to meet the growing global demand for its contact lenses.
-
Alcon Vision LLC has expanded its ophthalmic portfolio through acquisitions, portfolio expansion, and continuous innovation in presbyopia-correcting solutions. Supported by regulatory approvals and clinical advancements, the company’s PanOptix technology has surpassed 1 million implanted lenses worldwide, reflecting strong demand for advanced vision-correction technologies and increasing consumer preference for reduced dependence on spectacles.
This includes cutting-edge advancements in packaging and order fulfillment technologies. Additionally, CooperVision’s commitment to sustainability is evident with its LEED Silver-certified Scottsville facility, which manufactures products like the Biofinity toric lenses. Both of CooperVision’s major sites are powered entirely by renewable energy, aligning with their goal to reduce environmental impact while enhancing operational efficiency .
Alcon, on the other hand, has made noteworthy updates to its TOTAL30 product line, particularly in its toric lenses for astigmatism. As of November 2024, Alcon has expanded the fitting parameters of the TOTAL30 for Astigmatism, boosting its first-lens fit success rate to 95%. This new development is particularly beneficial for patients with more complex astigmatic prescriptions, who have previously had limited options for reusable toric lenses.
In addition to toric lenses, Alcon’s TOTAL30 product line has been expanded to include sphere and multifocal designs, which are now available with a full range of power parameters. This expansion reflects Alcon’s ongoing effort to meet the rising demand for high-performance, reusable lenses that provide both comfort and environmental benefits.
-
The Cooper Companies Inc. continues investing heavily in product development and innovation across daily disposable and specialty contact lens categories. Regulatory approvals and clinical advancements supporting next-generation lens technologies are expanding patient access to enhanced vision correction solutions, while growing R&D investments are accelerating development of smart, therapeutic, and drug-delivery contact lenses.